A design matrix of specialised service providers focused on your needs

Our own network of specialised service-provider companies allows us to carry out projects in a way that offers the client the advantage of specialisation and the flexibility of a personalised service as well as the strength of a group with centralised project management. The result for the client is a combination of dedication and flexibility throughout the project.

Businesswoman wearing a protective mask


Our four areas of activity

Early Drug Discovery

  • Target Identification & Validation
  • Hit Discovery
  • Assay Development & Screening
  • High Throughput Screening
  • Hit to Lead
  • Lead Optimisation

Clinical Development

  • Phase I – Healthy Volunteer Study
  • Phase II and Phase III – Studies in Patient Populations
  • Dose Escalation, Single Ascending & Multiple Dose Studies
  • Safety & Efficiancy
  • Pharmacokinetic Analysis
  • Bionanalytical Method Development & Validation
  • Marketing & Health Economics

Preclinical Studies

  • In Vivo, In Vitro & Ex Vivo Assays
  • ADME
  • Proof of Concept
  • Drug Delivery
  • Formulation Optimisation & Bioavailability
  • Dose Range Finding
  • IND-enabling Studies
  • IND Application

Regulatory & Registration

  • Regulatory Strategy
  • Scientific Advice
  • Clinical Protocol Design
  • Orphan Drug Applications
  • Regulatory and Medical Writing
  • Development of Investigationals Medicinal Product Dossier (IMPD)
  • Paediatric Investigation Plan (PIP)
  • Regulatory Submission Management

Find out more about our current and future projects!

Scroll to Top